| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Emory University School of Medicine and the VA Medical Center, Atlanta, GA.
Correspondence to: Mark S. Nanes, MD, PhD, VA Medical Center (111), 1670 Clairmont Rd, Decatur, GA 30033; e-mail: mnanes{at}emory.edu
Background: Men with chronic lung disease (CLD) are at risk for osteoporosis, but the relative contributions of their chronic pulmonary disease, glucocorticoid therapy, and other factors toward loss of bone has not been established. Understanding the relative importance of these factors would assist in selecting patients for bone densitometry screening and in policy decisions regarding Medicare reimbursement.
Objective: To identify patients with CLD who are most likely to benefit from bone densitometry screening based on clinical and biochemical measures.
Design: Cross-sectional medical survey.
Patients: Patients with CLD who were treated with either oral, inhaled, or no glucocorticoid therapy. A control group without lung disease was recruited from the same clinic population.
Measurements: Dual-energy X-ray absorptiometry was obtained for each group, and the association between bone mass and clinical variables, glucocorticoid use, gonadal hormones, and biochemical markers of bone metabolism was determined.
Results: Osteoporosis (a T score < -2.5 at the hip or spine) was five times as likely in patients with CLD as in control subjects. Although the prevalence of osteoporosis was higher (ninefold) after chronic glucocorticoid therapy, patients with CLD who had never been treated with glucocorticoids had a substantial (fourfold) risk of osteoporosis. Chronic inhaled glucocorticoid therapy offered no protection from bone loss compared to treatment with oral glucocorticoids. Of the clinical and biochemical measures that were obtained, bone mass was weakly correlated with body mass index (BMI), serum estradiol-17ß, and N-telopeptide, but not with testosterone, alkaline phosphatase, bone-specific alkaline phosphatase, or osteocalcin.
Conclusion: Patients with CLD should be considered for bone densitometry screening regardless of glucocorticoid use. Those patients with a low BMI and/or decreased serum estradiol-17ß comprise a subgroup with increased risk for osteoporosis.
Key Words: COPD • densitometry • fracture • male • osteoporosis
This article has been cited by other articles:
|
|
 |
|
  H. Liu, N. M. Paige, C. L. Goldzweig, E. Wong, A. Zhou, M. J. Suttorp, B. Munjas, E. Orwoll, and P. Shekelle Screening for Osteoporosis in Men: A Systematic Review for an American College of Physicians Guideline Ann Intern Med, May 6, 2008; 148(9): 685 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Caplan-Shaw, S. M. Arcasoy, E. Shane, D. J. Lederer, J. S. Wilt, M. K. O'Shea, V. Addesso, J. R. Sonett, and S. M. Kawut Osteoporosis in Diffuse Parenchymal Lung Disease Chest, January 1, 2006; 129(1): 140 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Mineo, V. Ambrogi, D. Mineo, A. Fabbri, E. Fabbrini, and R. Massoud Bone Mineral Density Improvement After Lung Volume Reduction Surgery for Severe Emphysema Chest, June 1, 2005; 127(6): 1960 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A A Ionescu When should we suspect osteoporosis in patients with chronic airways disease? Chronic Respiratory Disease, January 1, 2005; 2(1): 1 - 2. [PDF]
|
|
|
|
|
|
R. Aris, J. F. Donohue, and D. Ontjes Inhaled Corticosteroids and Fracture Risk: Having Our Cake and Eating It Too Chest, January 1, 2005; 127(1): 5 - 7. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sethi Musculoskeletal Effects of Chronic Obstructive Pulmonary Disease: Prevalent, Linked, but Ignored Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1267 - 1268. [Full Text] [PDF]
|
|
|
|
|
|
C. E. Bolton, A. A. Ionescu, K. M. Shiels, R. J. Pettit, P. H. Edwards, M. D. Stone, L. S. Nixon, W. D. Evans, T. L. Griffiths, and D. J. Shale Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1286 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Lee and K. B. Weiss Fracture Risk Associated with Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 855 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.A. Ionescu and E. Schoon Osteoporosis in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 64S - 75s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.C. Creutzberg and R. Casaburi Endocrinological disturbances in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 76S - 80s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Adler, H. L. Funkhouser, V. I. Petkov, B. L. Elmore, P. S. Via, C. T. McMurtry, and T. Adera Osteoporosis in Pulmonary Clinic Patients: Does Point-of-Care Screening Predict Central Dual-Energy X-ray Absorptiometry? Chest, June 1, 2003; 123(6): 2012 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Katsura and K. Kida A Comparison of Bone Mineral Density in Elderly Female Patients With COPD and Bronchial Asthma Chest, December 1, 2002; 122(6): 1949 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Johnell, R. Pauwels, C-G. Lofdahl, L.A. Laitinen, D.S. Postma, N.B. Pride, and S.V. Ohlsson Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Eur. Respir. J., June 1, 2002; 19(6): 1058 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Biskobing COPD and Osteoporosis Chest, February 1, 2002; 121(2): 609 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsumoto, K. Ishihara, T. Hasegawa, B.-i. Umeda, A. Niimi, and M. Hino Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients : A 4-Year Longitudinal Study Chest, November 1, 2001; 120(5): 1468 - 1473. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
